Fig. 1 | Signal Transduction and Targeted Therapy

Fig. 1

From: CRISPR base editor treats premature-aging syndrome

Fig. 1

Programmable base editing rescues Hutchinson–Gilford progeria syndrome. a A single base mutation at 1824 locus in LMNA gene results in mis-splicing and subsequently translates into a truncated lamin A protein, termed progerin, which causes Hutchinson–Gilford progeria syndrome (HGPS). b ABEmax-VRQR corrected human LMNA mutation in two primary fibroblast cells derived from HGPS patients. Using the lentiviral delivery delivered ABEmax-VRQR and sgRNA targeting LMNA c.1824 C > T mutation, resulting in gene editing of the LMNA loci and subsequently rescuing lamin A abundance and nuclear morphology. c ABEmax-VRQR treatment in HGPS mice model. Koblan et al. used the clinical adeno-associated virus vector for co-packaged ABEmax-VRQR to make the correction of mutation in many tissues, but not all, in mouse model, resulting in improved vascular pathology and extended the HGPS mice lifespan

Back to article page